What’s the best modality for patient selection for predicting response to PD-1/PD-L1 inhibitors?

Lignende værker

• Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
  af: Diggs, Laurence P., et al.
  Udgivet: (2017)
• Response to ‘The effect of PD-L1 testing on the cost-effectiveness of immune checkpoint inhibitors’
  af: Ogale, S
  Udgivet: (2018)
• Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
  af: Ming Yi, et al.
  Udgivet: (2018-08-01)
• Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
  af: Yi, Ming, et al.
  Udgivet: (2018)
• Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade: A Systematic Review and Meta-analysis
  af: Lu, Steve, et al.
  Udgivet: (2019)